SCOPE Summit 2026

Here’s what Aixial do to tackle the feasibility challenges in rare disease clinical trials. Rare disease trials require access-focused strategies

Effective aggregate safety reporting is a cornerstone of patient safety, regulatory compliance, and informed decision-making.

Check out our poster to dive deeper into the study, understand the methodology, and see the results firsthand.

This article outlines Aixial’s comprehensive best practices for operational oversight of safety system lifecycle management.

Ashley Hunter and Anna Yanaeva led an engaging discussion on the importance of “Utilising CROs for Effective Planning and Execution of Clinical Development”.

Radiopharmaceutical therapy utilizes radioactive atoms to target and precisely treat cancer cells.